Stock Track | Teladoc Health Plummets 5% as Widening Losses Overshadow In-Line Earnings

Stock Track

Feb 28, 2025

Teladoc Health Inc. (NYSE: TDOC) stock plummeted 5.05% in pre-market trading on Friday, as the company's widening losses overshadowed its in-line earnings performance for the full year 2024.

The virtual healthcare provider reported a net loss of $1.0 billion for the year, a staggering 354% increase from the previous year. Earnings per share deteriorated to a loss of $5.87, compared to a loss of $1.34 in 2023. Despite the mounting losses, Teladoc's revenue of $2.57 billion was in line with analyst estimates, though it declined 1.3% year-over-year.

The Integrated Care segment remained the primary revenue driver, contributing $1.53 billion (59% of total revenue). However, Teladoc's sales and marketing costs also ballooned to $910.8 million, accounting for a significant 32% of total expenses. Looking ahead, the company's revenue growth is projected to remain flat over the next three years, lagging behind the 9.6% growth forecast for the overall healthcare services industry in the US.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1121572225"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1121572225\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1121572225?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-28 22:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121572225","market":"us","top_or_hot":-1,"title":"Stock Track | Teladoc Health Plummets 5% as Widening Losses Overshadow In-Line Earnings","media":"Stock Track","content":"<p>Teladoc Health Inc. (NYSE: TDOC) stock plummeted 5.05% in pre-market trading on Friday, as the company's widening losses overshadowed its in-line earnings performance for the full year 2024.</p>\n\n<p>The virtual healthcare provider reported a net loss of $1.0 billion for the year, a staggering 354% increase from the previous year. Earnings per share deteriorated to a loss of $5.87, compared to a loss of $1.34 in 2023. Despite the mounting losses, Teladoc's revenue of $2.57 billion was in line with analyst estimates, though it declined 1.3% year-over-year.</p>\n\n<p>The Integrated Care segment remained the primary revenue driver, contributing $1.53 billion (59% of total revenue). However, Teladoc's sales and marketing costs also ballooned to $910.8 million, accounting for a significant 32% of total expenses. Looking ahead, the company's revenue growth is projected to remain flat over the next three years, lagging behind the 9.6% growth forecast for the overall healthcare services industry in the US.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Teladoc Health Plummets 5% as Widening Losses Overshadow In-Line Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Teladoc Health Plummets 5% as Widening Losses Overshadow In-Line Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-28 22:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Teladoc Health Inc. (NYSE: TDOC) stock plummeted 5.05% in pre-market trading on Friday, as the company's widening losses overshadowed its in-line earnings performance for the full year 2024.</p>\n\n<p>The virtual healthcare provider reported a net loss of $1.0 billion for the year, a staggering 354% increase from the previous year. Earnings per share deteriorated to a loss of $5.87, compared to a loss of $1.34 in 2023. Despite the mounting losses, Teladoc's revenue of $2.57 billion was in line with analyst estimates, though it declined 1.3% year-over-year.</p>\n\n<p>The Integrated Care segment remained the primary revenue driver, contributing $1.53 billion (59% of total revenue). However, Teladoc's sales and marketing costs also ballooned to $910.8 million, accounting for a significant 32% of total expenses. Looking ahead, the company's revenue growth is projected to remain flat over the next three years, lagging behind the 9.6% growth forecast for the overall healthcare services industry in the US.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TDOC","symbol_name":"Teladoc Health Inc.","start_time":0,"source_url":"","article_id":"1121572225","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121572225","pubTimestamp":1740753877,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Teladoc Health Inc.  stock plummeted 5.05% in pre-market trading on Friday, as the company's widening losses overshadowed its in-line earnings performance for the full year 2024.The virtual healthcare provider reported a net loss of $1.0 billion for the year, a staggering 354% increase from the previous year. Earnings per share deteriorated to a loss of $5.87, compared to a loss of $1.34 in 2023. Despite the mounting losses, Teladoc's revenue of $2.57 billion was in line with analyst estimates, ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TDOC":"Teladoc Health Inc."},"translate_title":"Teladoc Health股价暴跌5%，亏损扩大掩盖了预期盈利","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TDOC":1},"content_text":"Teladoc Health Inc. (NYSE: TDOC) stock plummeted 5.05% in pre-market trading on Friday, as the company's widening losses overshadowed its in-line earnings performance for the full year 2024.\nThe virtual healthcare provider reported a net loss of $1.0 billion for the year, a staggering 354% increase from the previous year. Earnings per share deteriorated to a loss of $5.87, compared to a loss of $1.34 in 2023. Despite the mounting losses, Teladoc's revenue of $2.57 billion was in line with analyst estimates, though it declined 1.3% year-over-year.\nThe Integrated Care segment remained the primary revenue driver, contributing $1.53 billion (59% of total revenue). However, Teladoc's sales and marketing costs also ballooned to $910.8 million, accounting for a significant 32% of total expenses. Looking ahead, the company's revenue growth is projected to remain flat over the next three years, lagging behind the 9.6% growth forecast for the overall healthcare services industry in the US.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}